Affordable Access

The CA125 regression rate to predict overall survival differ between paclitaxel-containing regimen and nonpaclitaxel regimen in patients with advanced ovarian cancer.

Authors
Type
Published Article
Journal
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Publication Date
Volume
12
Issue
5
Pages
435–437
Identifiers
PMID: 12366658
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments